Conference Coverage
Latest News
Remote teams offer chance to improve difficult-to-treat PsA
This difficult-to-treat cohort is discussed at ZOOM meetings, ranging from monthly to bimonthly, with two dermatologists, two rheumatologists, one...
Latest News
Keep depression, anxiety screening top of mind in patients with psoriatic disease
"Psoriasis patients are twice as likely to have depression, compared to those without psoriasis, and psoriasis patients are 33% more likely to...
Latest News
Experts call for early screening for chronic kidney disease
Nearly all patients seen in primary care are candidates for screening because of their risk factors for kidney disease, such as diabetes and...
Conference Coverage
U.S. states, counties with highest Alzheimer’s prevalence rates identified
“These new findings could help physicians treating or caring for minority populations “understand the landscape of what the disease looks like.”...
Latest News
Naltrexone is safe and beneficial in AUD with cirrhosis
VIENNA –
Conference Coverage
Debate: Initial combination therapy for type 2 diabetes?
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...
Conference Coverage
Does private equity ensure survival of GI practices?
Private equity offers the allure of financial and administrative stability.
Conference Coverage
Aging and type 1 diabetes: ‘Complete picture’ 40 years on
“The EDIC study is now shifting its focus during the next 5 years to understand the clinical course of type 1 diabetes in the setting of advancing...
Latest News
Finding mild cognitive impairment quickly in primary care
When it comes to treatment, deprescribing is a priority, as many drug interactions contribute to cognitive disorders.
Latest News
Oral IL-23 receptor antagonist for psoriasis promising: Phase 2b study
Similar to the primary outcome of PASI 75, all treatment groups demonstrated a statistically significant dose-response in PASI 90, compared with...
Latest News
JAK inhibitors efficacious for atopic dermatitis in Asian patients, study finds
The Singapore study is one of the few that have examined the safety and efficacy of JAK inhibitors for treatment of AD in a non-White population...